Indications for cardiac resynchronization therapy
Thomas M O'Brien1, Edward J Schloss1, Eugene S Chung1
1The Heart and Vascular Center, The Christ Hospital, 2139 Auburn Ave, Cincinnati, OH 45219, USA.
Insights
Cardiac resynchronization therapy (CRT) patient selection criteria have evolved. Newer guidelines emphasize specific QRS durations and left bundle branch morphology for improved patient outcomes in heart failure management.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Initial criteria for cardiac resynchronization therapy (CRT) included left ventricular ejection fraction ≤35%, QRS duration ≥120 ms, and New York Heart Association (NYHA) class 3-4.
- These criteria were based on early clinical studies and patient cohorts.
Purpose of the Study:
- To review and update patient selection criteria for CRT based on recent data.
- To identify patient subgroups most likely to benefit from CRT.
Main Methods:
- Analysis of post hoc data from clinical trials.
- Review of meta-analyses and updated clinical guidelines.
- Evaluation of specific electrocardiographic parameters like QRS duration and morphology.
Main Results:
- Refined criteria highlight the importance of QRS duration >150 ms and specific left bundle branch block morphology.
- These updated parameters improve the prediction of favorable outcomes with CRT.
- Guidelines continue to evolve with emerging evidence.
Conclusions:
- Patient selection for CRT requires ongoing refinement based on evolving data.
- A personalized approach balancing risks and benefits is crucial for optimal CRT application.
- Future guidelines will likely incorporate further data to optimize patient selection for CRT.
Abstract:
Initial studies established patient selection criteria for cardiac resynchronization therapy (CRT) as left ventricular ejection fraction less than or equal to 35%, QRS greater than or equal to 120 ms, and New York Heart Association 3-4. Based on newer data, post hoc analyses, and meta-analyses, these criteria have been refined and guidelines updated, highlighting left bundle branch morphology and QRS greater than 150 ms in selecting patients with a likelihood of favorable outcomes. Guidelines will change as more data become available; the decision to apply CRT should be based on patient clinical profile and the balance of risk tolerance and likelihood of benefit.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure IV: Classification and Diagnostic Evaluation


